|
| Maintenance ramucirumab monotherapy after intolerable toxicities following docetaxel plus ramucirumab |
|
https://doi.org/10.18632/oncotarget.25623
Akito Hata, and Nobuyuki Katakami
|
| 28292-28293 |
|
| BRAF inhibitors stimulate inflammasome activation and interleukin 1 beta production in dendritic cells |
|
https://doi.org/10.18632/oncotarget.25511
Eva Hajek, Franziska Krebs, Rebekka Bent, Katharina Haas, Antje Bast, Ivo Steinmetz, Andrea Tuettenberg, Stephan Grabbe, and Matthias Bros
|
| 28294-28308 |
|
| IL23 enhances the malignant properties of hepatoma cells by attenuation of HNF4α |
|
https://doi.org/10.18632/oncotarget.24875
Qing Jiang, Yuanli Sun, Zilong Guo, Ru Chen, Simin Ma, Mingpeng Fu, Huifen Zhu, Qin Ning, Ping Lei, and Guanxin Shen
|
| 28309-28321 |
|
| Proteomics identification and characterization of MbovP730 as a potential DIVA antigen of Mycoplasma bovis |
|
https://doi.org/10.18632/oncotarget.22265
Farhan Anwar Khan, Gang Zhao, Yusi Guo, Muhammad Faisal, Jin Chao, Xi Chen, Chenfei He, Harish Menghwar, Rahim Dad, Muhammad Zubair, Changmin Hu, Yingyu Chen, Huanchun Chen, Zhang Rui, and Aizhen Guo
|
| 28322-28336 |
|
| The human blood DNA methylome identifies crucial role of βcatenin in the pathogenesis of Kawasaki disease |
|
https://doi.org/10.18632/oncotarget.25305
Kuang-Den Chen, Ying-Hsien Huang, Mindy Ming-Huey Guo, Tzu-Yang Lin, Wei-Teng Weng, Hsiang-Jen Yang, Kuender D. Yang, and Ho-Chang Kuo
|
| 28337-28350 |
|
| Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis |
|
https://doi.org/10.18632/oncotarget.25322
Hideo Yuki, Takao Kamai, Satoshi Murakami, Satoru Higashi, Takahiro Narimatsu, Tsunehito Kambara, Hironori Betsunoh, Hideyuki Abe, Kyoko Arai, Hiromichi Shirataki, and Ken-Ichiro Yoshida
|
| 28351-28363 |
|
| Tumorderived granzyme Bexpressing neutrophils acquire antitumor potential after lipid A treatment |
|
https://doi.org/10.18632/oncotarget.25342
Amandine Martin, Cédric Seignez, Cindy Racoeur, Nicolas Isambert, Nesrine Mabrouk, Alessandra Scagliarini, Sylvie Reveneau, Laurent Arnould, Ali Bettaieb, Jean-François Jeannin, and Catherine Paul
|
| 28364-28378 |
|
| MicroRNA analysis of gastroenteropancreatic neuroendocrine tumors and metastases |
|
https://doi.org/10.18632/oncotarget.25357
Nadine Zimmermann, Juliana Knief, Tim Kacprowski, Pamela Lazar-Karsten, Tobias Keck, Franck Billmann, Sebastian Schmid, Kim Luley, Hendrik Lehnert, Georg Brabant, and Christoph Thorns
|
| 28379-28390 |
|
| MiR199a3p decreases esophageal cancer cell proliferation by targeting p21 activated kinase 4 |
|
https://doi.org/10.18632/oncotarget.25375
Pornima Phatak, Whitney M. Burrows, Ingrid E. Chesnick, Mohan E. Tulapurkar, Jaladanki N. Rao, Douglas J. Turner, Anne W. Hamburger, Jian-Ying Wang, and James M. Donahue
|
| 28391-28407 |
|
| Cancerrelated transcription regulator protein NAC1 forms a protein complex with CARM1 for ovarian cancer progression |
|
https://doi.org/10.18632/oncotarget.25400
Naomi Nakayama, Gyosuke Sakashita, Yuko Nariai, Hiroaki Kato, Kaori Sinmyozu, Jun-Ichi Nakayama, Satoru Kyo, Takeshi Urano, and Kentaro Nakayama
|
| 28408-28420 |
|
| Comparative molecular characterization of typical and exceptional responders in glioblastoma |
|
https://doi.org/10.18632/oncotarget.25420
Kristin Wipfler, Adam S. Cornish, and Chittibabu Guda
|
| 28421-28433 |
|
| Deferasirox an oral iron chelator with gemcitabine synergistically inhibits pancreatic cancer cell growth in vitro and in vivo |
|
https://doi.org/10.18632/oncotarget.25421
Shuhei Shinoda, Seiji Kaino, Shogo Amano, Hirofumi Harima, Toshihiko Matsumoto, Koichi Fujisawa, Taro Takami, Naoki Yamamoto, Takahiro Yamasaki, and Isao Sakaida
|
| 28434-28444 |
|
| Silencing NIK potentiates antiVEGF therapy in a novel 3D model of colorectal cancer angiogenesis |
|
https://doi.org/10.18632/oncotarget.25442
Chrissta X. Maracle, Kim C.M. Jeucken, Boy Helder, Thomas M. van Gulik, Anne Steins, Hanneke W.M. van Laarhoven, and Sander W. Tas
|
| 28445-28455 |
|
| Simultaneous delivery of olaparib and carboplatin in PEGylated liposomes imparts this drug combination hypersensitivity and selectivity for breast tumor cells |
|
https://doi.org/10.18632/oncotarget.25466
Vojtech Novohradsky, Juraj Zajac, Oldrich Vrana, Jana Kasparkova, and Viktor Brabec
|
| 28456-28473 |
|
| Role of drug transporters in the sensitivity of acute myeloid leukemia to sorafenib |
|
https://doi.org/10.18632/oncotarget.25494
Rocio I.R. Macias, Anabel Sánchez-MartÃn, Gabriela RodrÃguez-MacÃas, Luis I. Sánchez-Abarca, Elisa Lozano, Elisa Herraez, Maria D. Odero, José L. DÃez- MartÃn, Jose J.G. Marin, and Oscar Briz
|
| 28474-28485 |
|
| Efficacy of a new cancer treatment strategy based on eradication of tumorinitiating stem cells in a mouse model of Krebs2 solid adenocarcinoma |
|
https://doi.org/10.18632/oncotarget.25503
Ekaterina A. Potter, Anastasia S. Proskurina, Genrikh S. Ritter, Evgenia V. Dolgova, Valeriy P. Nikolin, Nelly A. Popova, Oleg S. Taranov, Yaroslav R. Efremov, Sergey I. Bayborodin, Aleksandr A. Ostanin, Elena R. Chernykh, Nikolay A. Kolchanov, and Sergey S. Bogachev
|
| 28486-28499 |
|
| A bispecific inhibitor targeting IL17A and MMP9 reduces invasion and motility in MDAMB231 cells |
|
https://doi.org/10.18632/oncotarget.25526
Dana Koslawsky, Marianna Zaretsky, Ron Alcalay, Ohad Mazor, Amir Aharoni, and Niv Papo
|
| 28500-28513 |
|
| Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells |
|
https://doi.org/10.18632/oncotarget.25530
Sony Pandey, Jennifer Bourn, and Maria Cekanova
|
| 28514-28531 |
|
| Prostate cancer susceptibility gene HIST1H1A is a modulator of androgen receptor signaling and epithelial to mesenchymal transition |
|
https://doi.org/10.18632/oncotarget.25536
Kendra A. Williams, Minnkyong Lee, Jean M. Winter, Derek E. Gildea, Carla Calagua, Natasha L. Curry, Jens Lichtenberg, Huihui Ye, and Nigel P.S. Crawford
|
| 28532-28546 |
|
| Targeting of BMI1 expression by the novel small molecule PTC596 in mantle cell lymphoma |
|
https://doi.org/10.18632/oncotarget.25558
Aya Maeda, Yuki Nishida, Marla Weetall, Liangxian Cao, Arthur Branstrom, Jo Ishizawa, Takenobu Nii, Wendy D. Schober, Yoshiaki Abe, Kosei Matsue, Mariko Yoshimura, Shinya Kimura, and Kensuke Kojima
|
| 28547-28560 |
|
| Ipilimumab plus nivolumab and DNArepair defects in ARV7expressing metastatic prostate cancer |
|
https://doi.org/10.18632/oncotarget.25564
Karim Boudadi, Daniel L. Suzman, Valsamo Anagnostou, Wei Fu, Brandon Luber, Hao Wang, Noushin Niknafs, James R. White, John L. Silberstein, Rana Sullivan, Donna Dowling, Rana Harb, Thomas R. Nirschl, Brendan A. Veeneman, Scott A. Tomlins, Yipeng Wang, Adam Jendrisak, Ryon P. Graf, Ryan Dittamore, Michael A. Carducci, Mario A. Eisenberger, Michael C. Haffner, Alan K. Meeker, James R. Eshleman, Jun Luo, Victor E. Velculescu, Charles G. Drake, and Emmanuel S. Antonarakis
|
| 28561-28571 |
|
| 2′deoxy2′[18F] fluoroDglucose positron emission tomography diffusionweighted magnetic resonance imaging and choline spectroscopy to predict the activity of cetuximab in tumor xenografts derived from patients with squamous cell carcinoma of the head and neck |
|
https://doi.org/10.18632/oncotarget.25574
Lionel Mignion, Sandra Schmitz, Nicolas Michoux, Xavier Caignet, Rose-Marie Goebbels, Anne Bol, Marie-Aline C. Neveu, Vincent Grégoire, Thierry Duprez, Renaud Lhommel, Fréderic Amant, Els Hermans, Benedicte F. Jordan, and Jean-Pascal Machiels
|
| 28572-28585 |
|
| The histone deacetylase inhibitor panobinostat is a potent antitumor agent in canine diffuse large Bcell lymphoma |
|
https://doi.org/10.18632/oncotarget.25580
Joana N.R. Dias, Sandra I. Aguiar, Diane M. Pereira, Ana S. André, Lurdes Gano, João D.G. Correia, Belmira Carrapiço, Barbara Rütgen, Rui Malhó, Conceição Peleteiro, João Goncalves, CecÃlia M.P. Rodrigues, Solange Gil, LuÃs Tavares, and Frederico Aires-da-Silva
|
| 28586-28598 |
|
| Thymoquinone challenges UHRF1 to commit autoubiquitination: a key event for apoptosis induction in cancer cells |
|
https://doi.org/10.18632/oncotarget.25583
Abdulkhaleg Ibrahim, Mahmoud Alhosin, Christophe Papin, Khalid Ouararhni, Ziad Omran, Mazin A. Zamzami, Abdulrahman Labeed Al-Malki, Hani Choudhry, Yves Mély, Ali Hamiche, Marc Mousli, and Christian Bronner
|
| 28599-28611 |
|
| PRex1 is dispensable for Erk activation and mitogenesis in breast cancer |
|
https://doi.org/10.18632/oncotarget.25584
Laura Barrio-Real, Cynthia Lopez-Haber, Victoria Casado-Medrano, Alexander G. Goglia, Jared E. Toettcher, Maria J. Caloca, and Marcelo G. Kazanietz
|
| 28612-28624 |
|
| RIOK1 kinase activity is required for cell survival irrespective of MTAP status |
|
https://doi.org/10.18632/oncotarget.25586
Alexandra Hörmann, Barbara Hopfgartner, Thomas Köcher, Maja Corcokovic, Teresa Krammer, Christoph Reiser, Gerd Bader, Junwei Shi, Katharina Ehrenhöfer, Simon Wöhrle, Norbert Schweifer, Christopher R. Vakoc, Norbert Kraut, Mark Pearson, Mark Petronczki, and Ralph A. Neumüller
|
| 28625-28637 |
|
| Oral administration of fructose exacerbates liver fibrosis and hepatocarcinogenesis via increased intestinal permeability in a rat steatohepatitis model |
|
https://doi.org/10.18632/oncotarget.25587
Kenichiro Seki, Mitsuteru Kitade, Norihisa Nishimura, Kosuke Kaji, Kiyoshi Asada, Tadashi Namisaki, Kei Moriya, Hideto Kawaratani, Yasushi Okura, Hiroaki Takaya, Yasuhiko Sawada, Shinya Sato, Keisuke Nakanishi, and Hitoshi Yoshiji
|
| 28638-28651 |
|
| Epithelial differentiation with microlumen formation in meningioma: diagnostic utility of NHERF1/EBP50 immunohistochemistry |
|
https://doi.org/10.18632/oncotarget.25595
Maria-Magdalena Georgescu, Adriana Olar, Bret C. Mobley, Phyllis L. Faust, and Jack M. Raisanen
|
| 28652-28665 |
|
| Role for the transcriptional activator ZRF1 in early metastatic events in breast cancer progression and endocrine resistance |
|
https://doi.org/10.18632/oncotarget.25596
Aysegül Kaymak, Sergi Sayols, Thaleia Papadopoulu, and Holger Richly
|
| 28666-28690 |
|
| Advantage of HSP110 T17 marker inclusion for microsatellite instability MSI detection in colorectal cancer patients |
|
https://doi.org/10.18632/oncotarget.25611
Gustavo Noriz Berardinelli, Cristovam Scapulatempo-Neto, RonÃlson Durães, Marco Antônio de Oliveira, Denise Guimarães, and Rui Manuel Reis
|
| 28691-28701 |
|
| Lysisindependent potentiation of immune checkpoint blockade by oncolytic virus |
|
https://doi.org/10.18632/oncotarget.25614
Anton Oseledchyk, Jacob M. Ricca, Mathieu Gigoux, Brian Ko, Gil Redelman-Sidi, Tyler Walther, Cailian Liu, Gopa Iyer, Taha Merghoub, Jedd D. Wolchok, and Dmitriy Zamarin
|
| 28702-28716 |
|
| Cancerpredicting transcriptomic and epigenetic signatures revealed for ulcerative colitis in patientderived epithelial organoids |
|
https://doi.org/10.18632/oncotarget.25617
Samaneh K. Sarvestani, Steven A. Signs, Veronique Lefebvre, Stephen Mack, Ying Ni, Andrew Morton, Ernest R. Chan, Xiaoxia Li, Paul Fox, Angela Ting, Matthew F. Kalady, Michael Cruise, Jean Ashburn, Jennifer Stiene, Wei Lai, David Liska, Shao Xiang, and Emina H. Huang
|
| 28717-28730 |
|
| Targeting Pololike kinase 1 and TRAIL enhances apoptosis in nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25618
Alfiah Noor, Ijeoma Adaku Umelo, Peter Kronenberger, Philippe Giron, Elly De Vlieghere, Olivier De Wever, Erik Teugels, and Jacques De Grève
|
| 28731-28744 |
|
| Growth hormonereleasing hormone GHRH and its agonists inhibit hepatic and tumoral secretion of IGF1 |
|
https://doi.org/10.18632/oncotarget.25676
Tengjiao Cui, and Andrew V. Schally
|
| 28745-28756 |
|
| Trends and outcomes of women with synchronous endometrial and ovarian cancer |
|
https://doi.org/10.18632/oncotarget.25550
Koji Matsuo, Hiroko Machida, Erin A. Blake, Laura L. Holman, Bobbie J. Rimel, Lynda D. Roman, and Jason D. Wright
|
| 28757-28771 |
|
| Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients |
|
https://doi.org/10.18632/oncotarget.25594
Sebastian Regnery, Sebastian Adeberg, Constantin Dreher, Johanna Oberhollenzer, Jan-Eric Meissner, Steffen Goerke, Johannes Windschuh, Katerina Deike-Hofmann, Sebastian Bickelhaupt, Moritz Zaiss, Alexander Radbruch, Martin Bendszus, Wolfgang Wick, Andreas Unterberg, Stefan Rieken, Jürgen Debus, Peter Bachert, Mark Ladd, Heinz-Peter Schlemmer, and Daniel Paech
|
| 28772-28783 |
|
| Induction chemotherapy reduces extracellular heat shock protein 72 levels inflammation lipoperoxidation and changes insulin sensitivity in children and adolescents newly diagnosed with acute lymphoblastic leukemia |
|
https://doi.org/10.18632/oncotarget.25609
Ana Paula Trussardi Fayh, Camila de Carvalho Gomes, Helena Trevisan Schroeder, Carlos Henrique de Lemos Muller, Telma Maria de Araújo Moura Lemos, and Mauricio Krause
|
| 28784-28795 |
|
| Correction: Genipin suppresses colorectal cancer cells by inhibiting the Sonic Hedgehog pathway |
|
https://doi.org/10.18632/oncotarget.25677
Bo Ram Kim, Yoon A. Jeong, Yoo Jin Na, Seong Hye Park, Min Jee Jo, Jung Lim Kim, Soyeon Jeong, Suk-Young Lee, Hong Jun Kim, Sang Cheul Oh, and Dae-Hee Lee
|
| 28796-28796 |
|
| Correction: Targeting Hsp27/eIF4E interaction with phenazine compound: a promising alternative for castrationresistant prostate cancer treatment |
|
https://doi.org/10.18632/oncotarget.25683
Hajer Ziouziou, Claudia Andrieu, Erik Laurini, Sara Karaki, Maurizio Fermeglia, Ridha Oueslati, David Taieb, Michel Camplo, Olivier Siri, Sabrina Pricl, Maria Katsogiannou, and Palma Rocchi
|
| 28797-28797 |
|
| Correction: Combining molecular and immunohistochemical analyses of key drivers in primary melanomas: interplay between germline and somatic variations |
|
https://doi.org/10.18632/oncotarget.25684
William Bruno, Claudia Martinuzzi, Bruna Dalmasso, Virginia Andreotti, Lorenza Pastorino, Francesco Cabiddu, Marina Gualco, Francesco Spagnolo, Alberto Ballestrero, Paola Queirolo, Federica Grillo, Luca Mastracci, and Paola Ghiorzo
|
| 28798-28798 |
